All intranasal articles
-
NewsIntranasal COVID-19 vaccine headed to clinical trials
CyanVac will sponsor a randomized, double-blind Phase 2b study to compare the efficacy and safety of CVXGA, its intranasal vaccine candidate designed to protect against COVID-19, against an FDA-approved mRNA-based COVID-19 vaccine.
-
NewsIntranasal COVID vaccine works against variants in animals
Researchers have developed an intranasal vaccine against Covid-19 that can fight off the original virus and two variants in hamsters.